The observed differences in angiogenic capacity are consistent with previous studies showing that lower levels of placental growth factor (PlGF) and VEGF and higher levels of sFlt1 determine the antiangiogenic properties of serum in preeclampsia (40, 47). This evidence concerns the gene VEGFA and preeclampsia.